Serum osteopontin: A new marker for renal cell cancer
The Journal of Urology（2005）
Abstract
You have accessJournal of UrologyVideo Session, Sunday, May 22, 2005 10:00 am - 12:00 pm1 Apr 2005373: Serum Osteopontin: A New Marker for Renal Cell Cancer Nathan Lawrentschuk, Zhanqi Liu, Ian D. Davis, Andrew M. Scott, and Damien M. Bolton Nathan LawrentschukNathan Lawrentschuk More articles by this author , Zhanqi LiuZhanqi Liu More articles by this author , Ian D. DavisIan D. Davis More articles by this author , Andrew M. ScottAndrew M. Scott More articles by this author , and Damien M. BoltonDamien M. Bolton More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)34626-3AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "373: Serum Osteopontin: A New Marker for Renal Cell Cancer." The Journal of Urology, 173(4S), p. 102 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 173Issue 4SApril 2005Page: 102 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Nathan Lawrentschuk More articles by this author Zhanqi Liu More articles by this author Ian D. Davis More articles by this author Andrew M. Scott More articles by this author Damien M. Bolton More articles by this author Expand All Advertisement PDF downloadLoading ...
MoreTranslated text
Key words
serum osteopontin,renal cell cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined